The present disclosure relates to an apparatus for treating spinal conditions, and more particularly, to an intervertebral implant.
The human spine includes thirty-three vertebrae. The vertebrae interlock with one another to form a spinal column. Each vertebra has a cylindrical bony body (vertebral body), two pedicles extending from the vertebral body, a lamina extending from the pedicles, two wing-like projections extending from the pedicles, a spinous process extending from the lamina, a pars interarticularis, two superior facets extending from the pedicles, and two inferior facets extending from the lamina. The vertebrae are separated and cushioned by thin pads of tough, resilient fiber known as inter-vertebral discs. Inter-vertebral discs provide flexibility to the spine and act as shock absorbers during activity. A small opening (foramen) located in each vertebra allows passage of the spinal cord. When the vertebrae are properly aligned, the spinal cord passes through without a problem. However, when the vertebrae are misaligned or a constriction is formed in the spinal canal, nerves of the spinal cord may get compressed and may cause back pain, leg pain, or other neurological disorders.
Disorders of the spine that may cause misalignment of the vertebrae or constriction of the spinal canal include spinal injuries, infections, tumor formation, herniation of the inter-vertebral discs (i.e., slippage or protrusion), arthritic disorders, and scoliosis. In these pathologic circumstances, surgery may be tried to either decompress the neural elements and/or fuse adjacent vertebral segments. Decompression may involve laminectomy, discectomy, or corpectomy. Laminectomy involves the removal of part of the lamina, i.e., the bony roof of the spinal canal. Discectomy involves removal of the inter-vertebral discs. Corpectomy involves removal of the vertebral body as well as the adjacent inter-vertebral discs.
A number of spinal surgical devices may be used to promote bony fusion after decompressing the spinal nerves. For instance, surgeons often replace the diseased vertebral tissue with one or more spinal cages and bone support matrix. Spinal cages support adjacent vertebral segments, while furthering spinal fusion of adjacent vertebral bodies. Scientists and clinicians have developed a number of devices and methods for decompressing spinal nerves. Improvements to these methods and devices are nevertheless still possible. Reference may be made to U.S. Patent Publication No. 2014/0277503 filed on Mar. 14, 2014, entitled “Spinal Fixation Device,” the entire content of which is incorporated herein by reference, for a detailed discussion of the construction and operation of a spinal fixation system and an instrumentation for use therewith.
Furthermore, intervertebral spacer implants used as a stand-alone device or provided in an assembly including a retention mechanism to help alleviate expulsion and movement of the implant when placed in the spine, are well known. Such implant assemblies are advantageous in providing an implant that is easier to insert in the spine. Intervertebral spacer implant assemblies which include a spacer and a plate, where the plate comprises a supplemental or alternative retention mechanism having one or more holes in the anterior end of the plate that are directed toward the superior, inferior or both end plates of adjacent vertebrae are also known in the art. Such implants are used to stabilize and immobilize the spinal segments in the treatment of single or multi-level degenerative disc disease, spinal stenosis, and failed previous fusions, as well as other spine conditions.
To meet the problem of preventing expulsion of the interbody device and for providing stability to the anatomy, a need exists for an spinal fixation device that can be secured to the spine and provide anterior column support and stabilization, while providing a maximum fusion area.
In accordance with an embodiment of the present disclosure, there is provided a spinal fixation device including an outer housing and an end plate assembly coupled with the outer housing. The outer housing defines an aperture and a longitudinal axis. At least a portion of the end plate assembly is slidably received within the outer housing through the aperture. The end plate assembly includes a first end plate configured to engage a vertebral body, wherein the end plate assembly is selectively movable between a first position in which the first end plate is spaced apart from the outer housing and a second position in which the first end plate is adjacent the outer housing. Further, the first end plate is selectively adjustable to an angular orientation of a plurality of angular orientations with respect to the longitudinal axis of the outer housing.
In an embodiment, the end plate assembly may include first and second elongate members operatively coupled to the first end plate such that axial movement of the first and second elongate members in tandem causes axial displacement of the first end plate, and relative movement between the first and second elongate members transitions the first end plate from a first angular orientation to a second angular orientation.
In another embodiment, the spinal fixation device may include a mounting assembly operatively supporting the first and second elongate members in the outer housing. The mounting assembly may be releasably secured with the outer housing. In yet another embodiment, the mounting assembly may include a retaining housing and first and second rotatable members rotatably supported in the retaining housing. The first and second rotatable members may be operatively coupled with the first and second elongate members of the end plate assembly. The first and second rotatable members of the mounting assembly may be spaced apart from each other to define a gap therebetween.
In an embodiment, each of the first and second rotatable members of the mounting assembly may include circumferentially arranged teeth opposing each other. The first rotatable member of the mounting assembly may include inner threads in a first orientation and the second rotatable member of the mounting assembly may include inner threads in a second orientation opposite to the first orientation.
The outer housing may define a plurality of bores. In particular, at least one bore of the plurality of bores may be in communication with the gap defined between the first and second rotatable members of the mounting assembly. The plurality of bores may be circumferentially arranged about the outer housing. The plurality of bores may be arranged along a length of the outer housing.
In accordance with another embodiment of present disclosure, there is provided a surgical kit including a spinal fixation device and a surgical instrument. The spinal fixation device includes an outer housing and an end plate assembly. The end plate assembly is coupled with the outer housing. At least a portion of the end plate assembly is slidably received within the outer housing through an aperture of the outer housing. The end plate assembly includes a first end plate configured to engage a vertebral body, wherein the end plate assembly is selectively movable between a first position in which the first end plate is spaced apart from the outer housing and a second position in which the first end plate is adjacent the outer housing. In addition, the first end plate is selectively adjustable to an angular orientation of a plurality of angular orientations with respect to the outer housing. The surgical instrument defines a channel extending therethrough. The surgical instrument defines an engaging portion configured to securely engage the outer housing of the spinal fixation device.
In an embodiment, the surgical instrument may include a height adjusting driver rotatably extending through the channel of the surgical instrument. The height adjusting driver may include an engaging portion having teeth configured to engage the circumferentially arranged teeth of the first and second rotatable members of the mounting assembly, whereby rotation of the height adjusting driver causes rotation of the first and second rotatable members of the mounting assembly.
In another embodiment, the surgical instrument may further include an angle adjusting driver rotatably extending through the channel of the surgical instrument. The angle adjusting driver may include an engaging portion having teeth configured to engage the circumferentially arranged teeth of one of the first or second rotatable members of the mounting assembly, whereby rotation of the angle adjusting driver causes rotation of the one of the first or second rotatable members of the mounting assembly.
In yet another embodiment, the kit may further include a rod connector having an anchoring portion coupled with the outer housing of the spinal fixation device and a head portion having a recessed portion configured to receive a spinal rod. In particular, the rod connector may define a channel therethrough. In addition, the head portion of the rod connector may define a bore in communication with the channel.
In yet another embodiment, the kit may further include a drug delivery assembly including a drug reservoir securely coupled with the outer housing of the spinal fixation device, a supply port, and a catheter in fluid communication with the supply port and the drug reservoir.
In yet another embodiment, the kit may further include a shield attachable to the spinal fixation device. In particular, the shield may be configured to reduce radiation to a spinal cord. Alternatively, the shield may include slow releasing medicament.
The above and other aspects and features of the present disclosure will become more apparent in light of the following detailed description when taken in conjunction with the accompanying drawings in which:
Particular embodiments of the present disclosure will be described herein with reference to the accompanying drawings. As shown in the drawings and as described throughout the following description, and as is traditional when referring to relative positioning on an object, the terms “proximal” and “trailing” may be employed interchangeably, and should be understood as referring to the portion of a structure that is closer to a clinician during proper use. The terms “distal” and “leading” may also be employed interchangeably, and should be understood as referring to the portion of a structure that is farther from the clinician during proper use. In addition, the term “cephalad” or “cranial” is used in this application to indicate a direction toward a patient's head, whereas the term “caudad” indicates a direction toward the patient's feet. Further still, the term “medial” indicates a direction toward the middle of the body of the patient, whilst the term “lateral” indicates a direction toward a side of the body of the patient (i.e., away from the middle of the body of the patient). The term “posterior” indicates a direction toward the patient's back, and the term “anterior” indicates a direction toward the patient's front. In the following description, well-known functions or constructions are not described in detail to avoid obscuring the present disclosure in unnecessary detail.
With reference to
End plate assembly 560 is configured as a modular assembly that is interchangeably mounted in outer housing 510. For example, a plurality of end plate assemblies 560 may be provided with varying parameters such as, e.g., footprint and lordosis, such that the clinician may selectively attach a desired end plate assembly 560 to outer housing 510 to meet the needs of each patient or surgical procedure being performed. In this manner, end plate assembly 560 may be tailored to achieve a desired lordosis of a first end plate 540 and a desired axial spacing between outer housing 510 and first end plate 540, as will be discussed hereinbelow.
Spinal fixation device 500 may be made of titanium, titanium alloy, stainless steel, allograft bone, autologous bone graft, polyetheretherketone (PEEK), cobalt chrome, polymeric materials, a combination thereof, or any other suitable biocompatible material. In particular, spinal fixation device 500 may be formed of bone, or an artificial material other than bone which may be harder or stronger than bone, such as, e.g., ceramic materials. Outer housing 510 may include a bone growth promoting material such as, e.g., bone morphogenic protein and hydroxyapatite. Outer housing 510 may define a cavity 551 to accommodate bone graft material therein.
With reference to
With particular reference to
With particular reference to
With continued reference to
First and second rotatable members 610, 612 include internal threads 609, 613 (
With continued reference to
With particular reference now to
First and second elongate members 666, 668 of end plate assembly 560 include outer threads 662, 664 configured to engage internal threads 609, 613 (
With reference now to
With reference now to
With reference now to
With reference now to
With reference now to
With reference to
With reference now to
With reference to
With reference now to
Therapeutic agents may include chemotherapeutic agents (for example, paclitaxel, vincristine, ifosfamide, dacttinomycin, doxorubicin, cyclophosphamide, and the like), bisphosphonates (for example, alendronate, pamidronate, clodronate, zoledronic acid, and ibandronic acid), analgesics (such as opioids and NSAIDS), anesthetics (for example, ketoamine, bupivacaine and ropivacaine), tramadol, and dexamethasone. In other variations, drug delivery assembly 1700 may be used for delivering an agent useful in radiotherapy in, e.g., beads.
As an alternative to systemic administration of radioactive agents that are capable of targeting a particular tissue, antigen, or receptor type, the radioactive agents are administered locally following implantation of spinal fixation device 500. Such radiotherapy agents include radiolabeled antibodies, radiolabeled peptide receptor ligands, or any other radiolabeled compound capable of specifically binding to the specific targeted cancer cells.
In addition, drug delivery assembly 1700 may be used to deliver drugs used in the management of pain and swelling that occurs following the implantation surgery. For example, spinal fixation device 500 may release an effective amount of an analgesic agent alone or in combination with an anesthetic agent. As yet another alternative, spinal fixation device 500 may be used to deliver drugs which help minimize the risk of infection following implantation. For example, spinal fixation device 500 may release one or more antibiotics (for example, cefazolin, cephalosporin, tobramycin, gentamycin, etc.) and/or another agent effective in preventing or mitigating biofilms (for example, a quorum-sensing blocker or other agent targeting biofilm integrity). Bacteria may form biofilms on the surface of spinal fixation device 500, and these biofilms may be relatively impermeable to antibiotics. Accordingly, systemically administered antibiotics may not achieve optimal dosing where it is most needed. However, spinal fixation device 500 enables the delivery of the desired dose of antibiotic precisely when and where needed. In certain circumstances, the antibiotic may be delivered beneath the biofilm.
With reference to
The drugs discussed hereinabove, may be supplied through supply port 1740 by a syringe 1750. It is also contemplated that drug reservoir 1720 may be preloaded with a predetermined amount of drugs to eliminate catheter 1730, supply port 1740, and syringe 1750. It is further contemplated that spinal fixation device 500 may include channels, pores, and/or passages (not shown) formed in, e.g., outer housing 510. The channels, pores, and/or passages may be in fluid communication with drug reservoir 1720 to facilitate delivery of the drugs from drug reservoir 1720 to the delivery target.
With reference to
With reference now to
Rod connector 2000 has a substantially similar configuration as rod connector 1000. The portions of rod connector 2000 that are identical to rod connector 1000, as discussed hereinabove, will not be discussed in detail. Rod connector 2000 includes an anchoring portion 2010, a coupling portion 2020 rotatably and pivotably coupled with anchoring portion 2010, and a head portion 2030. Anchoring portion 2010 includes an engaging portion 2012 configured to be threadably coupled with bore 527 of spinal fixation device 500. Coupling portion 2020 is secured with head portion 2030. Head portion 2030 includes a recessed portion 2032 configured to receive spinal rod 1500 therethrough. Head portion 2030 defines slits 2038 configured to flex or enlarge the dimensions of recessed portion 2032 to facilitate insertion of spinal rod 1500. Head portion 1030 further defines a bore 2034 configured to receive screw 1040. Upon insertion of spinal rod 1500 in recessed portion 2032, screw 1040 may be fastened to secure spinal rod 1500 in recessed portion 2032. Furthermore, head portion 2030 defines a bore 2050 in communication with the channel. Bore 2050 is dimensioned to receive seal member 2060 in a sealing relation. Under such a configuration, when the patient or the clinician supplies the drugs through supply port 1940 using, e.g., syringe 1750 (
With reference now to
With reference to
In use, the clinician first distracts vertebral bodies of interest to establish the intervertebral space. The clinician may then remove vertebral tissue, if necessary or desired. First and second elongate members 666, 668 of end plate assembly 560 are selectively positioned to achieve a desired orientation of first end plate 540. Insertion instrument 6000 is coupled with spinal fixation device 500 by, e.g., threadably, coupling engaging portion 6032 (
In addition, after removing height adjusting driver 7000 from insertion instrument 6000, angle adjusting driver 8000 can be inserted through channel 6035 (
At this time, rod connector 1000, pedicle screws 1600, and spinal rod 1500 may be utilized to further secure spinal fixation device 500 between vertebral bodies and to further promote spinal fusion. Anchoring portion 1010 of rod connector 1000 is threadably coupled with bore 527 of spinal fixation device 500, and pedicle screws 1600 are secured with respective vertebral bodies. Thereafter, spinal rod 1500 is inserted through recessed portion 1032 of rod connector 1000 and respective pedicle screws 1600. At this time, rod connector 1000 may be adjusted for proper angular orientation. Screw 1040 may be used to secure spinal rod 1500 in recessed portion 1032 of rod connector 1000 and the set screws (not shown) may be used to secure spinal rod 1500 with pedicle screws 1600. At this time, additional rod connector 1000 may be used to further secure spinal fixation device 500 between vertebral bodies. At this time, additional spinal rod 1500 may be utilized to further secure spinal fixation device 500 (
Based on the needs of the patient, drug delivery assemblies 1700, 1800, 1900, 3000 may be utilized to deliver the necessary drugs to the patient. To this end, drug reservoir 1720 of drug delivery assembly 1700 is secured with bore 527 of spinal fixation device 500. Supply port 1740 may be affixed to a location most convenient for the patient or the clinician to supply the drugs using, e.g., syringe 1750. Alternatively, cannula 1810 of drug delivery assembly 1800 is secured with bore 527 of spinal fixation device 500. The patient or the clinician may administer the drugs using syringe 1750. The use of drug delivery assemblies 1900, 2000 is substantially identical to the use of drug delivery assemblies 1700, 1800, and thus, will not be described herein. It is also contemplated that a drug pump such as, e.g., an insulin pump, may be connected to catheter 1730 to supply the drugs.
Although the illustrative embodiments of the present disclosure have been described herein with reference to the accompanying drawings, the above description, disclosure, and figures should not be construed as limiting, but merely as exemplifications of particular embodiments. For example, while the angular orientation of first end plate 560 is shown to be adjustable in cephalad and caudad directions, it is also contemplated that first end plate 560 may be adjustable in the medial and lateral directions. It is to be understood, therefore, that the disclosure is not limited to those precise embodiments, and that various other changes and modifications may be effected therein by one skilled in the art without departing from the scope or spirit of the disclosure.
This application claims priority to, and the benefit of, U.S. patent application Ser. No. 14/936,911, filed on Nov. 10, 2015, which claims priority to, and the benefit of, U.S. Provisional Patent Application Ser. No. 62/078,666, filed on Nov. 12, 2014. This application is also a continuation-in-part of U.S. patent application Ser. No. 14/212,236, filed on Mar. 14, 2014, which claims priority to, and the benefit of, U.S. Provisional Patent Application Ser. No. 61/781,837, filed on Mar. 14, 2013. The entire contents of each of these prior applications are incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
3374011 | Schipper | Mar 1968 | A |
3402947 | Lewis | Sep 1968 | A |
3588023 | Cohen | Jun 1971 | A |
3893730 | Homier et al. | Jul 1975 | A |
4387926 | Van Eerden et al. | Jun 1983 | A |
4554914 | Kapp et al. | Nov 1985 | A |
4938319 | Ernst | Jul 1990 | A |
5053036 | Perren et al. | Oct 1991 | A |
5108066 | Lundstrom | Apr 1992 | A |
5236460 | Barber | Aug 1993 | A |
5290312 | Kojimoto et al. | Mar 1994 | A |
5336223 | Rogers | Aug 1994 | A |
5360430 | Lin | Nov 1994 | A |
5458641 | Ramirez Jimenez | Oct 1995 | A |
5520690 | Errico et al. | May 1996 | A |
5547308 | Wright | Aug 1996 | A |
5571190 | Ulrich et al. | Nov 1996 | A |
5571192 | Schonhoffer | Nov 1996 | A |
5702455 | Saggar | Dec 1997 | A |
5723013 | Jeanson et al. | Mar 1998 | A |
5738685 | Halm et al. | Apr 1998 | A |
5776198 | Rabbe et al. | Jul 1998 | A |
5885286 | Sherman et al. | Mar 1999 | A |
5888014 | Lung et al. | Mar 1999 | A |
5901798 | Herrera et al. | May 1999 | A |
5904683 | Pohndorf et al. | May 1999 | A |
5980522 | Koros et al. | Nov 1999 | A |
5989290 | Biedermann et al. | Nov 1999 | A |
6074391 | Metz-Stavenhagen et al. | Jun 2000 | A |
6099531 | Bonutti | Aug 2000 | A |
6110172 | Jackson | Aug 2000 | A |
6132434 | Sherman et al. | Oct 2000 | A |
6176881 | Schar et al. | Jan 2001 | B1 |
6179514 | Cheng | Jan 2001 | B1 |
6183517 | Suddaby | Feb 2001 | B1 |
6193755 | Metz-Stavenhagen et al. | Feb 2001 | B1 |
6193756 | Studer et al. | Feb 2001 | B1 |
6200348 | Biedermann et al. | Mar 2001 | B1 |
6235062 | Gramnas | May 2001 | B1 |
6241769 | Nicholson et al. | Jun 2001 | B1 |
6254602 | Justis | Jul 2001 | B1 |
6273888 | Justis | Aug 2001 | B1 |
6296642 | Morrison et al. | Oct 2001 | B1 |
6296665 | Strnad et al. | Oct 2001 | B1 |
6302888 | Mellinger et al. | Oct 2001 | B1 |
6332895 | Suddaby | Dec 2001 | B1 |
6342074 | Simpson | Jan 2002 | B1 |
6364880 | Michelson | Apr 2002 | B1 |
6375683 | Crozet et al. | Apr 2002 | B1 |
6395034 | Suddaby | May 2002 | B1 |
6419705 | Erickson | Jul 2002 | B1 |
6423063 | Bonutti | Jul 2002 | B1 |
6440170 | Jackson | Aug 2002 | B1 |
6500178 | Zucherman et al. | Dec 2002 | B2 |
6524341 | Lang et al. | Feb 2003 | B2 |
6558423 | Michelson | May 2003 | B1 |
6562074 | Gerbec et al. | May 2003 | B2 |
6610090 | Bohm et al. | Aug 2003 | B1 |
6616695 | Crozet et al. | Sep 2003 | B1 |
6629998 | Lin | Oct 2003 | B1 |
6648917 | Gerbec et al. | Nov 2003 | B2 |
6660038 | Boyer, II et al. | Dec 2003 | B2 |
6663060 | Gifford, Sr. | Dec 2003 | B1 |
6716214 | Jackson | Apr 2004 | B1 |
6730088 | Yeh | May 2004 | B2 |
6752832 | Neumann | Jun 2004 | B2 |
6770096 | Bolger et al. | Aug 2004 | B2 |
6827719 | Ralph et al. | Dec 2004 | B2 |
6830589 | Erickson | Dec 2004 | B2 |
6834840 | Metz et al. | Dec 2004 | B1 |
6835196 | Biedermann et al. | Dec 2004 | B2 |
6837889 | Shluzas | Jan 2005 | B2 |
6843791 | Serhan | Jan 2005 | B2 |
6852129 | Gerbec et al. | Feb 2005 | B2 |
6863673 | Gerbec et al. | Mar 2005 | B2 |
6866682 | An et al. | Mar 2005 | B1 |
6869112 | Guidetti | Mar 2005 | B2 |
6869433 | Glascott | Mar 2005 | B2 |
6884244 | Jackson | Apr 2005 | B1 |
6893443 | Frigg et al. | May 2005 | B2 |
6896677 | Lin et al. | May 2005 | B1 |
6908485 | Crozet et al. | Jun 2005 | B2 |
6918911 | Biedermann et al. | Jul 2005 | B2 |
6945975 | Dalton | Sep 2005 | B2 |
6972019 | Michelson | Dec 2005 | B2 |
6984234 | Bray | Jan 2006 | B2 |
7001385 | Bonutti | Feb 2006 | B2 |
7025787 | Bryan et al. | Apr 2006 | B2 |
7033394 | Michelson | Apr 2006 | B2 |
7041135 | Michelson | May 2006 | B2 |
7052499 | Steger et al. | May 2006 | B2 |
7056343 | Schafer et al. | Jun 2006 | B2 |
7077864 | Byrd, III et al. | Jul 2006 | B2 |
7086631 | Lee et al. | Aug 2006 | B2 |
7087057 | Konieczynski et al. | Aug 2006 | B2 |
7094257 | Mujwid et al. | Aug 2006 | B2 |
7156874 | Paponneau et al. | Jan 2007 | B2 |
7175624 | Konieczynski et al. | Feb 2007 | B2 |
7229443 | Eberlein et al. | Jun 2007 | B2 |
7285134 | Berry et al. | Oct 2007 | B2 |
7318825 | Butler et al. | Jan 2008 | B2 |
7445627 | Hawkes et al. | Nov 2008 | B2 |
7527640 | Ziolo et al. | May 2009 | B2 |
7531002 | Sutton et al. | May 2009 | B2 |
7544208 | Mueller et al. | Jun 2009 | B1 |
7611104 | Gifford, Sr. | Nov 2009 | B1 |
7618456 | Mathieu et al. | Nov 2009 | B2 |
7651517 | Konieczynski et al. | Jan 2010 | B2 |
7691147 | Gutlin et al. | Apr 2010 | B2 |
7862616 | Lechmann et al. | Jan 2011 | B2 |
8137405 | Kostuik et al. | Mar 2012 | B2 |
8353961 | McClintock et al. | Jan 2013 | B2 |
8377101 | Barrus et al. | Feb 2013 | B2 |
8439977 | Kostuik et al. | May 2013 | B2 |
8585761 | Theofilos | Nov 2013 | B2 |
8663330 | McClintock et al. | Mar 2014 | B2 |
8673011 | Theofilos et al. | Mar 2014 | B2 |
8801791 | Soo et al. | Aug 2014 | B2 |
8814919 | Barrus et al. | Aug 2014 | B2 |
8920471 | Barrus et al. | Dec 2014 | B2 |
20010021851 | Eberlein et al. | Sep 2001 | A1 |
20020032443 | Sherman et al. | Mar 2002 | A1 |
20020128654 | Steger et al. | Sep 2002 | A1 |
20020161441 | Lang et al. | Oct 2002 | A1 |
20030130737 | McGahan et al. | Jul 2003 | A1 |
20030130739 | Gerbec et al. | Jul 2003 | A1 |
20030181980 | Berry et al. | Sep 2003 | A1 |
20040186569 | Berry | Sep 2004 | A1 |
20040247379 | Guidetti | Dec 2004 | A1 |
20050060034 | Berry et al. | Mar 2005 | A1 |
20050085910 | Sweeney | Apr 2005 | A1 |
20050209697 | Paponneau et al. | Sep 2005 | A1 |
20050218275 | Keating | Oct 2005 | A1 |
20050273173 | Gordon et al. | Dec 2005 | A1 |
20060041260 | Orbay | Feb 2006 | A1 |
20060074490 | Sweeney | Apr 2006 | A1 |
20060100710 | Gutlin et al. | May 2006 | A1 |
20060122701 | Kiester | Jun 2006 | A1 |
20060129244 | Ensign | Jun 2006 | A1 |
20060149251 | Ziolo et al. | Jul 2006 | A1 |
20060149385 | McKay | Jul 2006 | A1 |
20060173456 | Hawkes et al. | Aug 2006 | A1 |
20060200244 | Assaker | Sep 2006 | A1 |
20060212118 | Abernathie | Sep 2006 | A1 |
20060217715 | Serhan et al. | Sep 2006 | A1 |
20060241762 | Kraus | Oct 2006 | A1 |
20060241770 | Rhoda et al. | Oct 2006 | A1 |
20060271047 | Jackson | Nov 2006 | A1 |
20060276792 | Ensign et al. | Dec 2006 | A1 |
20070010887 | Williams et al. | Jan 2007 | A1 |
20070032871 | Michelson | Feb 2007 | A1 |
20070073298 | Beutter et al. | Mar 2007 | A1 |
20070093817 | Barrus et al. | Apr 2007 | A1 |
20070100340 | Lange et al. | May 2007 | A1 |
20070106231 | Snow et al. | May 2007 | A1 |
20070162126 | Karahalios et al. | Jul 2007 | A1 |
20070191954 | Hansell et al. | Aug 2007 | A1 |
20070219635 | Mathieu et al. | Sep 2007 | A1 |
20070250171 | Bonin | Oct 2007 | A1 |
20070255408 | Castleman et al. | Nov 2007 | A1 |
20070270964 | Strohkirch et al. | Nov 2007 | A1 |
20070270968 | Baynham et al. | Nov 2007 | A1 |
20070282441 | Stream et al. | Dec 2007 | A1 |
20080009946 | Douget et al. | Jan 2008 | A1 |
20080021555 | White et al. | Jan 2008 | A1 |
20080114467 | Capote et al. | May 2008 | A1 |
20080125864 | de Villiers et al. | May 2008 | A1 |
20080147193 | Matthis et al. | Jun 2008 | A1 |
20080167720 | Melkent | Jul 2008 | A1 |
20080249624 | Josimovic-Alasevic et al. | Oct 2008 | A1 |
20080249625 | Waugh et al. | Oct 2008 | A1 |
20080288071 | Biyani et al. | Nov 2008 | A1 |
20100005715 | Allsop et al. | Jan 2010 | A1 |
20100137919 | Wolter | Jun 2010 | A1 |
20100318092 | Butler et al. | Dec 2010 | A1 |
20110160861 | Jimenez et al. | Jun 2011 | A1 |
20110208248 | Barrus et al. | Aug 2011 | A1 |
20120179255 | DeFalco | Jul 2012 | A1 |
20140135931 | Popa et al. | May 2014 | A1 |
20140277503 | Mendel et al. | Sep 2014 | A1 |
Number | Date | Country |
---|---|---|
19804765 | Aug 1999 | DE |
1878408 | Jan 2008 | EP |
2902315 | Dec 2007 | FR |
01560184 | Apr 1990 | SU |
9846173 | Oct 1998 | WO |
03032812 | Apr 2003 | WO |
2008005627 | Jan 2008 | WO |
2009023016 | Feb 2009 | WO |
Entry |
---|
Australian Examination Report for Application No. 2015255166 dated Sep. 17, 2019, 1 page. |
Australian Examination Report for Application No. 2015255166, dated Aug. 11, 2020, 1 page. |
European Search Report for EP15194277 dated Feb. 23, 2016. |
European Comminucation issued in corresponding European Appln No. 15194277.8 dated Feb. 23, 2017. |
European Search Report dated May 28, 2009 from corresponding EP Appln. No. EP09152270.6 filed Feb. 6, 2009. |
International Search Report from PCT/US2009/038787 dated May 27, 2009. |
International Search Report for PCT/US2009/038780 dated Nov. 13, 2009. |
Extended European Search Report including Written Opinion for EP09724564 dated Dec. 7, 2012. |
Extended European Search Report including Written Opinion for EP15194277.8 dated Mar. 3, 2016. |
Number | Date | Country | |
---|---|---|---|
20190231557 A1 | Aug 2019 | US |
Number | Date | Country | |
---|---|---|---|
62078666 | Nov 2014 | US | |
61781837 | Mar 2013 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14936911 | Nov 2015 | US |
Child | 16379331 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14212236 | Mar 2014 | US |
Child | 14936911 | US |